Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
Jian Xu(University of California, Los Angeles), Yu Cao(Kunming Medical University), Mingxuan Cui(Tianjin Medical University), Rui Su(City of Hope), Lihua Yan(Tianjin People's Hospital), Xiaomin Shen(Tianjin People's Hospital), Bo Zhang(Tianjin Medical University)
Cited by 9
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145